ADC Therapeutics SA Files 8-K

Ticker: ADCT · Form: 8-K · Filed: Jun 5, 2025 · CIK: 1771910

Adc Therapeutics SA 8-K Filing Summary
FieldDetail
CompanyAdc Therapeutics SA (ADCT)
Form Type8-K
Filed DateJun 5, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k, corporate-governance

TL;DR

ADC Therapeutics SA filed an 8-K on June 3, 2025, for security holder votes and financial filings.

AI Summary

ADC Therapeutics SA filed an 8-K on June 3, 2025, to report on matters submitted to a vote of security holders and to file financial statements and exhibits. The filing does not contain specific details on the vote outcomes or financial figures within the provided text.

Why It Matters

This filing indicates that ADC Therapeutics SA has submitted matters for a vote by its security holders and is providing required financial statements and exhibits to the SEC.

Risk Assessment

Risk Level: low — The filing is a routine procedural report and does not contain new material financial information or significant operational updates that would immediately impact risk.

Key Players & Entities

  • ADC Therapeutics SA (company) — Registrant
  • June 3, 2025 (date) — Date of Earliest Event Reported
  • Switzerland (location) — State or Other Jurisdiction of Incorporation
  • 001-39071 (other) — Commission File Number
  • Biopôle Route de la Corniche 3B 1066 Epalinges Switzerland (address) — Address of Principal Executive Offices

FAQ

What specific matters were submitted to a vote of security holders by ADC Therapeutics SA?

The provided text of the 8-K filing does not specify the exact matters submitted to a vote of security holders.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on June 3, 2025.

What is the Commission File Number for ADC Therapeutics SA?

The Commission File Number for ADC Therapeutics SA is 001-39071.

Where are the principal executive offices of ADC Therapeutics SA located?

The principal executive offices of ADC Therapeutics SA are located at Biopôle Route de la Corniche 3B, 1066 Epalinges, Switzerland.

What is the standard industrial classification for ADC Therapeutics SA?

The standard industrial classification for ADC Therapeutics SA is Pharmaceutical Preparations [2834].

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 5, 2025 regarding ADC Therapeutics SA (ADCT).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.